Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05463939 |
Title | Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma Patients |
Recruitment | Approved for marketing |
Gender | both |
Phase | Expanded access |
Variant Requirements | No |
Sponsors | Janssen Research & Development, LLC |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries |